H.R. 3605 (98th): Drug Price Competition and Patent Term Restoration Act of 1984

Introduced:

Jul 19, 1983
98th Congress, 1983–1984

Status:
Died in a previous Congress

This bill was introduced in a previous session of Congress and was passed by the House on September 6, 1984 but was never passed by the Senate.

Sponsor:

Henry Waxman

Representative for California's 24th congressional district

Democrat

About the bill

Full Title

A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize an abbreviated new drug application under section 505 of that Act for generic new drugs equivalent to approved new drugs.

The bill’s titles are written by its sponsor.

Read CRS Summary >

History

Jul 19, 1983
 
Introduced

This is the first step in the legislative process.

Jun 12, 1984
 
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Sep 6, 1984
 
Passed House

The bill was passed in a vote in the House. It goes to the Senate next.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: